ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant cocktail aims to tame blood cancer without severe side effects
Disease control Recruiting nowThis early-stage trial is testing a new combination of chemotherapy drugs (thiotepa, busulfan, and fludarabine) followed by a stem cell transplant for people with certain blood cancers like leukemia and myelodysplastic syndrome. The goal is to see if this approach can reduce the …
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Phase: PHASE1 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New CAR T-Cell therapy aims to stop High-Risk leukemia from returning
Disease control Recruiting nowThis Phase 2 trial is testing whether a CAR T-cell therapy called obecabtagene autoleucel (obe-cel) can help control newly diagnosed, high-risk B-cell acute lymphoblastic leukemia (ALL) after initial treatment. The study will enroll 30 adults with high-risk features who are in fi…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC